Clonazepam (Page 7 of 7)

PRINCIPAL DISPLAY PANEL — 0.5 mg

NDC 17856-0133-1

CLONAZEPAM CIV
TABLETS, USP 0.5 mg

Rx Only

100 TABLETS PER CASE

image 1
(click image for full-size original)
CLONAZEPAM clonazepam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:17856-0133(NDC:16729-136)
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CLONAZEPAM (CLONAZEPAM) CLONAZEPAM 0.5 mg
Inactive Ingredients
Ingredient Name Strength
ANHYDROUS LACTOSE
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
CELLULOSE, MICROCRYSTALLINE
STARCH, CORN
FD&C YELLOW NO. 6
Product Characteristics
Color orange Score 2 pieces
Shape ROUND Size 8mm
Flavor Imprint Code 1;2
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:17856-0133-1 100 POUCH in 1 BOX, UNIT-DOSE contains a POUCH
1 1 TABLET in 1 POUCH This package is contained within the BOX, UNIT-DOSE (17856-0133-1)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077147 07/18/2018
Labeler — ATLANTIC BIOLOGICALS CORP. (047437707)
Establishment
Name Address ID/FEI Operations
ATLANTIC BIOLOGICALS CORP. 047437707 repack (17856-0133), relabel (17856-0133)

Revised: 03/2020 ATLANTIC BIOLOGICALS CORP.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.